|
Re: preclinical: metronomic chemotherapy (oral) produced remarkable prolongn of survi
Really interesting why most oncs are not trying this continuous low dose approach. As i have posted before my new onc initially offered me low dose xeloda with 3 weekly herceptin but under peer pressure withdrew the offer saying it would affect tmy quality of life! Going to have another go next week!
Elllie
|